NCT00382785

Brief Summary

Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. This objective will be addressed by the following specific aims:

  1. 1.Specific Aim #1 is to determine if there is a difference in depressive symptoms between women with breast cancer assigned to one of two treatment conditions: moderated online support or peer-led online support.
  2. 2.H1: Women with breast cancer who participate in moderated online support will report fewer depressive symptoms than women with breast cancer in peer led online support.
  3. 3.Specific Aim #2 is to determine if there is a difference in perceived social support between women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
  4. 4.H2: Women with breast cancer who participate in moderated online support will report greater perceived social support than women with breast cancer in peer-led online support.
  5. 5.Specific Aim #3 is to determine if there is a difference in quality of life in women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
  6. 6.H3: Women with breast cancer who participate in moderated online support will report better quality of life than women with breast cancer in peer-led online support. NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we decided to omit a "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable breast-cancer

Timeline
Completed

Started Sep 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2006

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

September 28, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 2, 2006

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

December 21, 2010

Completed
Last Updated

December 21, 2010

Status Verified

November 1, 2010

Enrollment Period

2.8 years

First QC Date

September 28, 2006

Results QC Date

September 29, 2010

Last Update Submit

November 23, 2010

Conditions

Keywords

onlinesupportbreast cancer

Outcome Measures

Primary Outcomes (3)

  • Scores on the Personal Resource Questionnaire 85.

    The Personal Resource Questionnaire 85 (PRQ85), Part II measures perceived social support and consists of 25 items in a seven-point Likert format which are rated from seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicative of higher levels of perceived social support. Alpha reliability of the PRQ 85 has been demonstrated at \>.90

    16 weeks

  • Scores on the CES-D Scale

    The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report scale widely used in the assessment of depression. Each item is given a rating of 0 to 3, with a potential range of 0 to 60 for the entire scale. Higher scores are associated with depression. The cutoff for the diagnosis of Major Depressive Disorder on the CES-D is 16. The instrument is a reliable measure (Alpha \>.85) of depression

    16 weeks

  • Scores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).

    The Rotterdam Symptom Checklist (RSCL) measures quality of life in cancer patients. The RSCL checklist includes a QOL life question on a scale of 1 (excellent) to 7 (extremely poor). This was used as a measure of overall QOL.

    16 weeks

Study Arms (2)

moderated online support

EXPERIMENTAL

12-week online support led by a healthcare professional

Behavioral: moderated support

peer-led support

EXPERIMENTAL

12-week online support group in a peer-led format

Behavioral: peer-led

Interventions

one 12-week online support group led by a professional healthcare provider

moderated online support
peer-ledBEHAVIORAL

12-week online support in a peer-led format

peer-led support

Eligibility Criteria

Age21 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female
  • At least 21 years of age
  • Internet access; Able to read and write English
  • Have completed treatment for breast cancer in the past 36 months or are receiving treatment
  • Do not currently belong to an online or face-to-face cancer support group
  • Internet access

You may not qualify if:

  • Male
  • not diagnosed with breast cancer
  • under 21 years of age
  • received treatment more than 36 months ago for breast cancer
  • no Internet access
  • unable to read and write English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Delaware

Newark, Delaware, 19716, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Limitations and Caveats

One limitation was the lack of a control group of women who did not take part in an online or face-to-face support group. The reasons for this are explained above.

Results Point of Contact

Title
Paula Klemm, PhD, RN, OCN
Organization
University of Delaware

Study Officials

  • Paula Klemm, PhD

    University of Delaware School of Nursing

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 28, 2006

First Posted

October 2, 2006

Study Start

September 1, 2006

Primary Completion

July 1, 2009

Study Completion

July 1, 2009

Last Updated

December 21, 2010

Results First Posted

December 21, 2010

Record last verified: 2010-11

Locations